AI-generated summary
This study protocol describes a planned randomized, double-blind, placebo-controlled crossover trial of LED phototherapy in patients with type 2 diabetes. Participants will receive both LED therapy and placebo before moderate cycling exercise, and the authors will measure oxygen uptake, muscle oxygenation, heart rate and arterial pressure. The authors state they hypothesize phototherapy may help optimize aerobic fitness, but no results are reported.
- Who or what was studied
- Patients with type 2 diabetes mellitus
- Wavelengths
- 850 nm
- Limits stated in the abstract
- This is a study protocol only, so no results or outcomes are reported yet.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Type 2 diabetes mellitus (DM) is responsible for a significant reduction in the quality of life due to its negative impact on functional capacity. Cardiopulmonary fitness impairment in DM patients has been associated with limited tissue oxygenation. Phototherapy is widely utilized to treat several disorders due to expected light-tissue interaction. This type of therapy may help to improve muscular oxygenation, thereby increasing aerobic fitness and functional capacity.
Methods/Design
This study is a randomized, double-blind, placebo-controlled crossover trial approved by the Ethics Committee of the Federal University of São Carlos and registered at ClinicalTrials.gov. Four separate tests will be performed to evaluate the acute effect of phototherapy. All participants will receive both
Interventions In Random Order
light-emitting diode therapy (LEDT) and placebo, with a minimum 14-day interval between sessions (washout period). Immediately after the intervention, participants will perform moderate constant workload cycling exercise corresponding to 80 % of the pulmonary oxygen uptake [Formula: see text] during the gas exchange threshold (GET). LEDT will be administered with a multidiode cluster probe (50 GaAIA LEDs, 850 ηm, 75 mW each diode, and 3 J per point) before each exercise session. Pulmonary oxygen uptake, muscle oxygenation, heart rate, and arterial pressure will be measured using a computerized metabolic cart, a near-infrared spectrometer, an electrocardiogram, and a photoplethysmography system, respectively.
Discussion
The main objective of this study is to evaluate the acute effects of muscular pre-conditioning using LED phototherapy on pulmonary oxygen uptake, muscle oxygenation, heart rate, and arterial pressure dynamics during dynamic moderate exercise. We hypothesize that phototherapy may be beneficial to optimize aerobic fitness in the DM population. Data will be published after the study is completed.
Trial Registration
Registered at ClinicalTrials.gov under trial number NCT01889784 (date of registration 5 June 2013).
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Power
- 75 mW
- Total energy
- 3 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Light-emitting diode, Phototherapy, Randomized controlled trial, Placebo-controlled, Trial registration, Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.